It should be noted that STAT3 mutations (present in 40% to 50% of T-LGLL) are the most common type of gain-of-function (GOF) genetic lesions among T-LGLL patients. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.